SHH and nevoid basal cell carcinoma syndrome: The major breakthrough in the understanding of Shh signaling in cancer came from the discovery that mutations in PTCH1 were the cause of Gorlin syndrome suggesting that aberrant Shh pathway activity was responsible for the development of these cancers [48,49].